ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CELU Celularity Inc

3.13
0.01 (0.32%)
Last Updated: 00:48:04
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Celularity Inc CELU NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.32% 3.13 00:48:04
Open Price Low Price High Price Close Price Previous Close
3.21 3.08 3.2101 3.12
more quote information »

Recent News

Date Time Source Heading
22/4/202422:00GLOBECelularity Inc. to Host Investor and Analyst Research &..
20/4/202407:30GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
19/4/202406:30GLOBECelularity Abstract “Emerging Technologies for the..
15/4/202422:00GLOBECelularity Announces Net Sales Trending Ahead of..
08/4/202423:00GLOBECelularity to Present Data Showing Senescent Cell..
27/3/202400:00GLOBECelularity Receives Healthcare Common Procedure Coding..
21/3/202400:15GLOBECelularity Submits Request to U.S. FDA for Orphan Drug..
15/3/202400:15GLOBECelularity CEO to Present on Cell Therapy’s Potential to..
13/3/202400:20GLOBECelularity CEO to Present Keynote Address at 2024 Society..
08/3/202401:35GLOBECelularity to Present Data Showing Cancer Tumor Reduction by..
27/2/202409:15EDGAR2Form 8-K - Current report
24/2/202408:10GLOBECelularity Announces 1-for-10 Reverse Stock Split
23/2/202401:05EDGAR2Form 8-K - Current report
22/2/202413:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202408:05GLOBECelularity’s Tri-layer Decellularized, Dehydrated Human..
13/2/202408:15EDGAR2Form 8-K - Current report
02/2/202422:01EDGAR2Form DEF 14A - Other definitive proxy statements
02/2/202401:00GLOBECelularity Announces Net Sales Expectations for First..
26/1/202401:00GLOBECelularity and Genting Leaders Comments on Closing $21..
23/1/202422:02EDGAR2Form PRE 14A - Other preliminary proxy statements
19/1/202405:40GLOBECelularity Releases CEO Letter to Shareholders
18/1/202409:15EDGAR2Form SC 13D/A - General statement of acquisition of..
18/1/202408:14EDGAR2Form 8-K - Current report
10/1/202408:49EDGAR2Form 8-K - Current report
05/1/202405:00GLOBECelularity Confirms Commercialization Agreement with..
04/1/202404:00GLOBECelularity Announces Net Sales and Total Revenue..
30/12/202308:47EDGAR2Form 8-K - Current report
25/11/202305:46EDGAR2Form 8-K - Current report
25/11/202305:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
19/10/202300:00GLOBECelularity Announces Commercial Biomaterial Products..
17/10/202311:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202310:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/9/202323:25EDGAR2Form 8-K - Current report
08/9/202306:21EDGAR2Form 8-K - Current report
08/9/202306:10GLOBECelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to..
29/8/202323:15EDGAR2Form 8-K - Current report
29/8/202323:00GLOBECelularity Announces Multi-Year Research Collaboration..
26/8/202306:06EDGAR2Form 8-K - Current report
15/8/202307:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202306:16EDGAR2Form 8-K - Current report
29/7/202306:27EDGAR2Form 8-K - Current report
29/7/202306:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/7/202323:07GLOBECelularity Inc. Announces $3 Million Registered Direct..
27/7/202323:00GLOBECelularity and Verséa Ophthalmics Announce Exclusive U.S...
20/7/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202323:00GLOBECelularity Human Placental-Derived Advanced Biomaterials..

Your Recent History

Delayed Upgrade Clock